摘要
目的探讨壳脂胶囊联合干扰素及利巴韦林治疗慢性丙型肝炎合并非酒精性脂肪肝的临床疗效。方法慢性丙型肝炎合并非酒精性脂肪性肝炎患者,排除肝硬化、其他病毒性肝炎、酒精性脂肪肝等。随机分成治疗组和对照组,对照组采用一般治疗及干扰素联合利巴韦林抗病毒治疗,治疗组则在此基础上加用壳脂胶囊。分析治疗前后2组患者抗病毒疗效及肝功能改善情况。结果治疗组抗病毒治疗优于对照组,肝功能恢复情况优于对照组。结论壳脂胶囊能改善丙型肝炎合并非酒精性脂肪肝的抗病毒疗效。
Objective To investigate the role of KEZHI capsule and IFN in treatment of patients with hepatitis C combined with nonalcoholic fatty liver disease （NAFLD）. Methods 115 patients with hepatitis C combined with nonal- coholic fatty liver disease, without liver cirrhosis, other viral hepatitis and alcoholic fatty liver were divided randomly into observation group and control group. The patients in observation group were treated with clinical routine therapy and antivirus therapy by IFN and ribavirin. The patients in control group were treated with both antivirus therapy and KEZHI capsule. The effect of antivirus and recovery of liver function were analyzed in 2 groups pre and post treatment. Results The effect of antivirus and recovery of liver function were better in observation group than those in control group. Conclusion KEZHI capsule can improve the antivirus effect in patients with hepatitis C combined with nonalcoholic fatty liver disease（NAFLD） , and it can improve the recovery of liver function.
出处
《胃肠病学和肝病学杂志》
CAS
2013年第3期224-225,共2页
Chinese Journal of Gastroenterology and Hepatology
关键词
壳脂胶囊
脂肪肝
丙型肝炎
干扰素
KEZHI capsule
Fatty liver disease
Hepatitis C
IFN
